'Robust evidence' Covid blood-thinning drug does more harm than good, concludes new study

A blood-thinning drug used to treat COVID-19 has been deemed too risky to administer in a new UK Government-funded trial.

This article, images and content belong to the source and curated for informational purposes.

‘Robust evidence’ Covid blood-thinning drug does more harm than good, concludes new study